30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Ensysce Biosciences Inc (ENSC)

Track

Stock chart
Ticker: ENSC Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GOWER BOB G
1 purchase — total 44,087 USD
Buy 2 Mar 2023
Value US$2,601,360.78 | Price 120.09 | Shares 22,970
Buy 1 Mar 2023
Value US$500,305.26 | Price 451.86 | Shares 81,742
Buy 28 Feb 2023
Value US$53,371.19 | Price 0.49 | Shares 109,300
Buy 9 Dec 2022
Value US$500,000.20 | Price 1.40 | Shares 357,143
Buy 26 May 2022
Value US$14,215.50 | Price 0.53 | Shares 27,000
Buy 25 May 2022
Value US$34,083.00 | Price 0.49 | Shares 70,000
Sale 19 Jun 2020
Value US$0.00 | Price 0.00 | Shares 776,290
Buy 1 Dec 2017
Value US$10,000,000.00 | Price 10.00 | Shares 1,000,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-06 2023-03-02 B Purchase
GOWER BOB G
Non-Executive Director
22,970 -37.1%
120.09
US$2,601,361 		22,970 -37.1% 120.09 US$2,601,361
2023-03-02 2023-03-01 B Purchase
GOWER BOB G
Non-Executive Director
81,742 +30.7%
451.86
US$500,305 		81,742 +30.7% 451.86 US$500,305
2023-03-02 2023-02-28 B Purchase
GOWER BOB G
Non-Executive Director
66,885 +34.9%
221.68
US$1,923,261 		66,885 +34.9% 221.68 US$1,923,261
2023-02-01 2022-12-09 B Purchase
GOWER BOB G
Non-Executive Director
357,143 +90.2%
1.40
US$500,000 		357,143 +90.2% 1.40 US$500,000
2022-05-27 2022-05-26 B Purchase
Kirkpatrick Lynn

Chief Executive Officer

Executive Director
27,000 +7.6%
0.53
US$14,216 		27,000 +7.6% 0.53 US$14,216
2022-05-27 2022-05-25 B Purchase
Kirkpatrick Lynn

Chief Executive Officer

Executive Director
70,000 +24.6%
0.49
US$34,083 		70,000 +24.6% 0.49 US$34,083
2020-06-23 2020-06-19 S Sale
0.7
MORGAN STANLEY
Large shareholder
776,290
0.00
US$0 		776,290 0.00 US$0
2018-01-17 2017-12-01 B Purchase HG Vora Capital Management, LLC Large shareholder
1,000,000 +35.2%
10.00
US$10,000,000 		1,000,000 +35.2% 10.00 US$10,000,000
Explore more

More insider trading research around Ensysce Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America